These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction. Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707 [TBL] [Abstract][Full Text] [Related]
3. Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction. Van Dreden P; Rousseau A; Savoure A; Lenormand B; Fontaine S; Vasse M Blood Coagul Fibrinolysis; 2009 Dec; 20(8):635-41. PubMed ID: 19809306 [TBL] [Abstract][Full Text] [Related]
4. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Jude B; Agraou B; McFadden EP; Susen S; Bauters C; Lepelley P; Vanhaesbroucke C; Devos P; Cosson A; Asseman P Circulation; 1994 Oct; 90(4):1662-8. PubMed ID: 7923650 [TBL] [Abstract][Full Text] [Related]
5. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance]. Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778 [TBL] [Abstract][Full Text] [Related]
6. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166 [TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [TBL] [Abstract][Full Text] [Related]
8. Cellular activation responses in blood in relation to lipid pattern: healthy men and women in families with myocardial infarction or cancer. Østerud B; Elvevoll EO; Brox J; Olsen JO Blood Coagul Fibrinolysis; 2002 Jul; 13(5):399-405. PubMed ID: 12138367 [TBL] [Abstract][Full Text] [Related]
9. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction. Gram J Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835 [TBL] [Abstract][Full Text] [Related]
11. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis]. Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633 [TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina. Habib SS; Abdel Gader AG; Kurdi MI; Suriya MO; Al Aseri Z J Pak Med Assoc; 2012 Jul; 62(7):681-5. PubMed ID: 23866515 [TBL] [Abstract][Full Text] [Related]
14. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. He M; Wen Z; He X; Xiong S; Liu F; Xu J; Li J; Xie Q; Jian Z; Chen F; Xiao B; Pu X; He S Thromb Res; 2002 Sep; 107(5):223-8. PubMed ID: 12479882 [TBL] [Abstract][Full Text] [Related]
15. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044 [TBL] [Abstract][Full Text] [Related]
16. Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction. Figueras J; Monasterio J; Lidón RM; Sambola A; Garcia-Dorado D Thromb Res; 2012 Sep; 130(3):458-62. PubMed ID: 22424853 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology. Tiefenbrunn AJ; Robinson AK; Kurnik PB; Ludbrook PA; Sobel BE Circulation; 1985 Jan; 71(1):110-6. PubMed ID: 4038368 [TBL] [Abstract][Full Text] [Related]
18. Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction. Stangl K; Laule M; Tenckhoff B; Stangl V; Gliech V; Dübel P; Grohmann A; Melzer C; Langel J; Wernecke KD; Baumann G; Ziemer S Am J Cardiol; 1998 Apr; 81(7):841-7. PubMed ID: 9555772 [TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
20. Blood coagulability and fibrinolytic activity before and after physical training during the recovery phase of acute myocardial infarction. Suzuki T; Yamauchi K; Yamada Y; Furumichi T; Furui H; Tsuzuki J; Hayashi H; Sotobata I; Saito H Clin Cardiol; 1992 May; 15(5):358-64. PubMed ID: 1623656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]